In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria

[1]  P. Turner,et al.  AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  J. Bellido,et al.  In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. , 2003 .

[3]  E. Goldstein,et al.  In Vitro Activities of Dalbavancin and Nine Comparator Agents against Anaerobic Gram-Positive Species and Corynebacteria , 2003, Antimicrobial Agents and Chemotherapy.

[4]  E. Goldstein,et al.  In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical Isolates , 2003, Antimicrobial Agents and Chemotherapy.

[5]  J. L. Muñoz Bellido,et al.  In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. , 2003, International journal of antimicrobial agents.

[6]  Ronald N. Jones,et al.  In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species. , 2002, Diagnostic microbiology and infectious disease.

[7]  G. Funke,et al.  Natural Antibiotic Susceptibility of Recently Established Coryneform Bacteria , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[8]  Albert Balows,et al.  Manual of Clinical Microbiology, 7th ed. , 2000 .

[9]  F. Soriano,et al.  In Vitro Susceptibilities of Aerobic and Facultative Non-Spore-Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other Antimicrobials , 1998, Antimicrobial Agents and Chemotherapy.

[10]  M. Collins,et al.  Actinomyces europaeus sp. nov., isolated from human clinical specimens. , 1997, International journal of systematic bacteriology.

[11]  B. Schneider,et al.  Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes. , 1997, The Journal of antimicrobial chemotherapy.

[12]  G. Eliopoulos,et al.  In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria , 1997, Antimicrobial agents and chemotherapy.

[13]  K. Bernard,et al.  Clinical microbiology of coryneform bacteria , 1997, Clinical microbiology reviews.